## BACKGROUND. Small cell carcinoma of the lung (SCLC) is distinguished from nonsmall cell carcinoma (NSCLC) by its exquisite initial sensitivity to chemotherapy. Antineoplastic drugs effective against SCLC include doxorubicin, etoposide, and others. Recently, the molecular target of these drugs h
β‐tubulin isotype classes II and V expression patterns in nonsmall cell lung carcinomas
✍ Scribed by Cucchiarelli, Valeria ;Hiser, Laree ;Smith, Hilda ;Frankfurter, Anthony ;Spano, Anthony ;Correia, John J. ;Lobert, Sharon
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 219 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0886-1544
- DOI
- 10.1002/cm.20297
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mutations in the tumor suppressor gene transforming growth factor β (TGFB) Type II receptor (__TGFBR2__) are frequently found in many cancers with microsatellite instability, but are less common in lung cancer. In the present study, we looked for mutations in __TGFBR2__ in nonsmall cell
## Background: The rat PC12 pheochromocytoma cell line provides an established system for the study of neuronal differentiation. To our knowledge, glial differentiation has not been reported in this cell line. Methods: We have studied, by immunohistochemistry and immunoblotting, the presence of n